Evidence map›Paper›PMID 35675120›Full record

Trial reportJournal of medical Internet research2022

A Pharmacy-Based eHealth Intervention Promoting Correct Use of Medication in Patients With Asthma and COPD: Nonrandomized Pre-Post Study.

Kyma Schnoor, Anke Versluis, Robbert Bakema, Sanne van Luenen, Marcel J Kooij, J Maurik van den Heuvel, Martina Teichert, Persijn J Honkoop, Job F M van Boven, Niels H Chavannes and 1 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Journal of medical Internet research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Methods to assess COPD medications adherence in healthcare databases: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  4. Article
  5. Article
  6. Article
  7. Digital Health Education for Chronic Lung Disease: Scoping Review.Journal of medical Internet research · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Kyma SchnoorDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0003-0265-8503
Anke VersluisDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-9489-7925
Robbert BakemaNederlandse Service Apotheek Beheer, 's Hertogenbosch, Netherlands.ORCID 0000-0001-7848-1930
Sanne van LuenenDepartment of Clinical Psychology, Leiden University, Leiden, Netherlands.ORCID 0000-0002-7871-5888
Marcel J KooijService Pharmacy Koning, Amsterdam, Netherlands.ORCID 0000-0002-6221-8561
J Maurik van den HeuvelDepartment of Respiratory Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.ORCID 0000-0003-2775-7276
Martina TeichertDepartment of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0001-8411-3325
Persijn J HonkoopDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0003-2051-4183
Job F M van BovenDepartment of Clinical Pharmacy and Pharmacology, Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.ORCID 0000-0003-2368-2262
Niels H ChavannesDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-8607-9199
Jiska J AardoomDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.ORCID 0000-0002-4023-6814
Leiden University Medical Center · NLLeiden University · NLUniversity Medical Center Groningen · NLUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAsthma and chronic obstructive pulmonary disease (COPD) affect millions of people worldwide. While medication can control and improve disease symptoms, incorrect use of medication is a common problem. The eHealth intervention SARA (Service Apothecary Respiratory Advice) aims to improve participants' correct use of inhalation medication by providing information and as-needed tailored follow-up support by a pharmacist.

objectiveThe primary aim of this study was to investigate the effect of SARA on exacerbation rates in participants with asthma and COPD. Secondary aims were to investigate its effects in terms of adherence to maintenance medication and antimycotic treatment.

methodsIn this nonrandomized pre-post study, medication dispensing data from 382 Dutch community pharmacies were included. Exacerbation rates were assessed with dispensed short-course oral corticosteroids. Medication adherence between new and chronic users was assessed by calculating the proportion of days covered from dispensed inhalation maintenance medication. Antimycotic treatment was investigated from dispensed oral antimycotics in participants who were also dispensed inhaled corticosteroids (ICS). Outcomes were assessed 1 year before and 1 year after implementation of SARA and were compared between SARA participants and control participants. More specifically, for exacerbation rates and medication adherence, a difference score was calculated (ie, 1 year after SARA minus 1 year before SARA) and was subsequently compared between the study groups with independent-samples t tests. For antimycotics, the relative number of participants who were dispensed antimycotics was calculated and subsequently analyzed with a mixed-effects logistic regression.

resultsThe study population comprised 9452 participants, of whom 2400 (25.39%) were SARA participants. The mean age of the population was 60.8 (15.0) years, and approximately two-thirds (n=5677, 60.06%) were female. The results showed an increase in mean exacerbation rates over time for both study groups (SARA: 0.05; control: 0.15). However, this increase in exacerbation rates was significantly lower for SARA participants (t

conclusionsThis study provides preliminary evidence that the SARA eHealth intervention might have the potential to decrease exacerbation rates and improve medication adherence among patients with asthma and COPD.

Indexed as

AsthmaPharmaciesPharmacyPulmonary Disease, Chronic ObstructiveTelemedicineAdministration, InhalationAdrenal Cortex HormonesFemaleHumansMaleMedication AdherenceMiddle AgedAdrenal Cortex HormonesasthmaCOPDeHealthexacerbationsmedication adherencepharmacy

Identifiers

PMID35675120
PMCPMC9218880
OpenAlexW4282913945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.